What Life Sciences Companies Need To Know In 2023

Life sciences companies are both benefiting and being challenged by the volume and complexity of data. The evolution toward the adoption of decentralized clinical trials, mandated use of real-world data and additional emphasis on health equity may be seen as burdens but they can be opportunities.

Join our expert panel to learn their perspectives on the innovations and advances that are taking place, and how the key will be to simplify the complexity of data to provide meaningful value and actionable insights. Our experts will be discussing the use of real-world data to support regulatory decisions and approvals, personalized treatments through digital technologies and therapies, maximizing value and efficiency with data and analytics, focus on health equity and user centricity in technology.